Latest "Pappas Ventures" News Stories

06:01 EST 14th November 2018 | BioPortfolio

Here are the most relevant search results for "Pappas Ventures" found in our extensive news archives from over 250 global news sources.

More Information about Pappas Ventures on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pappas Ventures for you to read. Along with our medical data and news we also list Pappas Ventures Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pappas Ventures Companies for you to search.

Showing "Pappas Ventures" News Articles 1–25 of 1,200+

Extremely Relevant

Ribometrix Launches with $30 Million to Develop RNA Structure-based Drugs

Ribometrix closed on a Series A financing worth $30 million. The round was led by M Ventures, with participation of new investors Amgen Ventures, Pappas Capital and Illumina Ventures.

VelosBio closes $58mm Series A round

Oncology start-up VelosBio Inc. raised $58mm through its Series A round. Arix Bioscience and Sofinnova Ventures co-led and we...


Startup Future Family rakes in $10M to expand subscription fertility service

Aspect Ventures led the $10 million Series A round. BBG Ventures, LaunchCapital, iNovia, RiverPark Ventures, Ulu Ventures, Day One Ventures and Portfolia participated.

Arix Bioscience appoints Arthur Pappas to its board

Evidation completes $15mm Series B round

Evidation Health Inc. (digital medicines) closed a $15mm Series B round from new backers B Capital Group (lead) and Pappas Ve...

League raises fresh capital to grow employee health benefits platform

The Canadian startup secured C$62 million (or about $47.5 million) in a round led by TELUS Ventures. Wittington Ventures, OMERS, RBC Ventures, Real Ventures, Infinite Potential Group and BDC IT Venture Fund also participated in the round.

Neurotherapeutics discovery start-up System1 closes $25mm Series A round

System1 Biosciences Inc. (neurological and psychiatric disorder drug discovery using phenotypic screening) completed a $25mm ...

StrideBio gets $15.7mm via Series A

StrideBio Inc. (developing novel adeno-associated viral (AAV) vectors for in vivo gene therapies aimed at rare diseases) rais...

Series B round brings $12.6mm to Gauss Surgical

Gauss Surgical Inc. (markets the Triton system for real-time blood loss monitoring during surgery and childbirth) raised $12....

AI firm Atomwise secures $45mm Series A round

Atomwise Inc. (AI using deep neural networks for drug discovery) closed a $45mm Series A round co-led by Monsanto Growth Vent...

Glympse Bio raises $22mm through Series A round

Diagnostics firm Glympse Bio Inc. raised $22mm through its Series A round that was co-led by LS Polaris Innovation Fund and A...

Brain-machine interface start-up Paradromics brings in $7mm in seed funding

Paradromics Inc. (implantable brain-machine interface (BMI) technology) brought in $7mm in a seed financing round co-led by A...

Mental health startup SonderMind brings in $2.5M seed round

Kickstart Seed Fund led the round, and Purple Arch Ventures, SpringTime Ventures, Service Provider Capital and Lanoha Ventures also participated.

Series E round brings $85.4mm to Sutro Biopharma

Sutro Biopharma Inc. (oncology) raised $85.4mm through its Series E round. Samsara BioCapital and Surveyor Capital co-led and...

Evolve brings in $40mm via Series C

Evolve BioSystems Inc. (develops products to restore and maintain a healthy gut microbiome in infants) raised $40mm in its Se...

mPulse Mobile Lands $11M, Launches Activation Intelligence Solution to Drive Behavior Change

mPulse Mobile, a provider of mobile solutions to drive healthy behavior change has raised $11 million in Series B funding led by SJF Ventures including existing investors HLM Venture Partners, EchoHealth Ventures, OCA Ventures, and Bonfire Ventures. That latest round brings the company’s total funding to date to over $25 million.  In addition to the ... Read More

The Importance of Funding Early Innovation. Roel Bulthuis, Head of MS Ventures.

MS Ventures is the strategic, corporate venture arm of the biopharmaceutical division of Merck KGaA, Darmstadt, Germany. They invest globally in emerging biotechnology companies that develop products and or technologies that have the potential to significantly improve patient outcomes. Along with the €100 million MS Ventures fund, their team also manages the €30 million Entrepreneur Partnershi...

HiFiBio raises $37.5mm in Series B round

Therapeutic antibody developer HiFiBio Therapeutics raised $37.5mm through an oversubscribed Series B round led by Sequoia Ch...

MedCrypt brings in $1.9M to advance medical device cybersecurity

Eniac Ventures led the seed round. Nex Cubed, Oronoco Investments, Sway Ventures and Friedman BioVentures also participated.

Celsius Therapeutics Launches with $65 Million Series A

The financing was led by Third Rock Ventures with participation from GV (formerly Google Ventures), Heritage Provider Network, Casdin Capital, Alexandria Venture Investments and others.

Gauss Surgical raises $12mm in Series A round

Gauss Surgical Inc. raised $12mm through its Series A round from Promus Ventures (led and takes a board seat), Summation Heal...

Digital pathology company exits stealth mode with $3.2M in funding

The startup, Deep Lens, is supported by seed financing from Sierra Ventures, Rev1 Ventures and Tamarind-Hill Fund.

Index Ventures, GSK and Johnson & Johnson launch exciting new Venture Fund

In this interview, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to Francesco de Rubertis of Index Ventures, Paul Stoffels, Worldwide Chairman of Johnson & Johnson Pharmaceuticals and Moncef Slaoui, Chairman of Research and Development at GSK about the launch of Index Ventures' new fund, IL

iBeat secures funding from insurers

Life insurer funds Transamerica Ventures and SCOR Life & Health Ventures have made an investment "upward of seven figures" in -More- 

Madaket Health raises $10M to facilitate smoother payer-provider data exchange

Qiming Venture Partners led the Series B round, which also saw participation from Salesforce Ventures, Experian Ventures and The PNC Financial Services Group.

Quick Search


News Quicklinks